Dow Up 1.31% Nasdaq Up 2.40%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
5.82 Down 0.12(2.02%) 4:00PM EDT
Prev Close:5.94
Open:6.07
Bid:5.50 x 2000
Ask:6.07 x 8300
1y Target Est:9.50
Beta:1.73
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.74 - 6.07
52wk Range:1.77 - 7.63
Volume:670,250
Avg Vol (3m):2,382,100
Market Cap:458.04M
P/E (ttm):N/A
EPS (ttm):-0.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for FOLD

Comparison

Symbol% ChgMkt Cap
FOLDDown 2.02%458.04M
SHPGUp 0.66%36.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):361.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.94
Quarterly EPS Est (Sep-14) :-0.21
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback